01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

01Overview 02Daily Brief 03Live 04Congress 05Corporate Insiders 06Government Money 07Political Influence 08Institutions 09Washington Network 10Follow the Power 11Disclosure Clock 12AI Investigator 13Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Overview Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Methodology Match review Launch readiness

Data sources

SEC FORM 44h ago

HOUSE PTR4h ago

SEC 13F4h ago

ROBINHOOD CHAIN4h ago

Public company

DXCMDEXCOM INC

CIK 0001093557

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections5with evidence

DXCM · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
← Lobbied forevidence
ALSTON & BIRD LLPLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
← Lobbied forevidence
FARRAGUT PARTNERS LLPLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
← Lobbied forevidence
CONTINENTAL STRATEGY, LLCLDA Q1 2026 first quarter · Health issues, MED · Aug 26, 2026
← Lobbied forevidence

BGR GOVERNMENT AFFAIRS

LDA RR 2026 second quarter · Medicare/Medicaid · Aug 26, 2026

Lobbying

$750K reported · de-duplicated

2026 Q2 $370K in-house2026 Q1 $380K in-house

FARRAGUT PARTNERS LLP$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
In-house report$370K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Trade, Health issues
ALSTON & BIRD LLP$40K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid
BGR GOVERNMENT AFFAIRS$40K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
CONTINENTAL STRATEGY, LLC$75K2026 Q2 · posted Aug 26, 2026 · Health issues, MED
CONTINENTAL STRATEGY, LLC$75K2026 Q1 · posted Aug 26, 2026 · Health issues, MED
In-house report$380K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Trade
FARRAGUT PARTNERS LLP$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
BGR GOVERNMENT AFFAIRS—2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
ALSTON & BIRD LLP$40K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.